SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): February 20, 2003 (February
19, 2003)
ENDO PHARMACEUTICALS HOLDINGS INC.
| DELAWARE | 39040 | 13-4022871 | ||||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
||||
| 100 Painters
Drive Chadds Ford, Pennsylvania |
19317 |
|||
| (Address of principal executive offices) | (Zip Code) | |||
(610) 558-9800
N/A
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 9. Regulation FD Disclosure. | ||||||||
| SIGNATURES | ||||||||
| INDEX TO EXHIBITS | ||||||||
| PRESS RELEASE | ||||||||
Item 7. Financial Statements and Exhibits.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
| Exhibit Number | Description | |
| 99.1 | Press Release of Endo Pharmaceuticals Holdings Inc. dated February 19, 2003 |
Item 9. Regulation FD Disclosure.
On February 19, 2003, the Registrant issued a press release, a copy of which is attached as Exhibit 99.1 to this Report and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| ENDO PHARMACEUTICALS HOLDINGS INC. (Registrant) | ||||
| By: | /s/ CAROL A. AMMON | |||
| Name: Carol A. Ammon Title: Chairman & Chief Executive Officer |
||||
Dated: February 20, 2003
INDEX TO EXHIBITS
| Exhibit Number | Description | |
| 99.1 | Press Release of Endo Pharmaceuticals Holdings Inc. dated February 19, 2003 |